Trial Profile
A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Depoxythilone (UTD1) in Patients with Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Depoxythilone (Primary) ; Antineoplastics
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2009 New trial record